Home › Funds › Solel Partners LP › CVS

Solel Partners LP position in CVS

CVS HEALTH CORP · Consumer Staples

Solel Partners LP reported holding 39,400 shares of CVS (CVS HEALTH CORP) in its Q2 2026 13F filing — a position valued at US$4.1M, representing 0.69% of its reported portfolio and ranking #20 among its reported holdings. Solel Partners LP has disclosed CVS holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)39.40K sh
Reported value held$4.08M
Portfolio Weight0.69%
First reportedQ2 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Solel Partners LP's CVS position evolved

Solel Partners LP first disclosed a stake in CVS in Q2 2024 at 503,400 shares (US$29.7M). The position peaked in Q3 2024 at 1,128,900 shares, worth US$71.0M. Across 9 filings, Solel Partners LP increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 39,400 shares valued at US$4.1M — a reduction of -454,300 shares quarter over quarter.. Notable position changes include a 124% increase in Q3 2024 (shares fell 28% over the following quarter), a 46% trim in Q1 2025 (shares rose 3% over the following quarter), a 92% trim in Q2 2026 (shares fell 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 503.40K $29.73M New
Q3 2024 1.13M $70.99M Add
Q4 2024 1.42M $63.94M Add
Q1 2025 774.30K $52.46M Reduce
Q2 2025 674.30K $46.51M Reduce
Q3 2025 713.70K $53.81M Add
Q4 2025 593.70K $47.12M Reduce
Q1 2026 493.70K $35.46M Reduce
Q2 2026 39.40K $4.08M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CVS and 13F data

CVS (CVS HEALTH CORP) is a Consumer Staples company. 39 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$7.75B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CVS

All CVS fund holders →

FAQ

How long has Solel Partners LP held CVS?

Solel Partners LP has disclosed CVS holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is Solel Partners LP's current position in CVS?

As of Q2 2026, Solel Partners LP holds 39.40K shares of CVS (CVS HEALTH CORP), valued at $4.08M, representing 0.69% of its reported portfolio and ranking #20.

Has Solel Partners LP been buying or selling CVS?

In the latest 13F filing (Q2 2026), Solel Partners LP reduced its position in CVS. The position peaked in Q3 2024 at 1.13M shares.

Which other funds hold CVS?

Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.